Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene
- 351 Downloads
Despite advances in surgery, chemotherapy and radiotherapy, the outcomes of patients with GBM have not significantly improved. Tumor recurrence in the resection margins occurs in more than 80 % of cases indicating aggressive treatment modalities, such as gene therapy are warranted. We have examined photochemical internalization (PCI) as a method for the non-viral transfection of the cytosine deaminase (CD) suicide gene into glioma cells. The CD gene encodes an enzyme that can convert the nontoxic antifungal agent, 5-fluorocytosine, into the chemotherapeutic drug, 5-fluorouracil. Multicell tumor spheroids derived from established rat and human glioma cell lines were used as in vitro tumor models. Plasmids containing either the CD gene alone or together with the uracil phosphoribosyl transferase (UPRT) gene combined with the gene carrier protamine sulfate were employed in all experiments.PCI was performed with the photosensitizer AlPcS2a and 670 nm laser irradiance. Protamine sulfate/CD DNA polyplexes proved nontoxic but inefficient transfection agents due to endosomal entrapment. In contrast, PCI mediated CD gene transfection resulted in a significant inhibition of spheroid growth in the presence of, but not in the absence of, 5-FC. Repetitive PCI induced transfection was more efficient at low CD plasmid concentration than single treatment. The results clearly indicate that AlPcS2a-mediated PCI can be used to enhance transfection of a tumor suicide gene such as CD, in malignant glioma cells and cells transfected with both the CD and UPRT genes had a pronounced bystander effect.
KeywordsGlioma Gene Therapy PDT PCI Cytosine deaminase 5-FC
This work was supported by grants from the Norwegian Radium Hospital Research Foundation and the Chao Cancer Center. Portions of this work were made possible through access to the Laser Microbeam and Medical Program (LAMMP) and the Chao Cancer Center Optical Biology Shared Resource at the University of California, Irvine.
- 1.Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRefGoogle Scholar
- 5.Moolton F (1986) Tumor chemosensitivity conferred by inserted herpes thymidine-kinase genes: paradigm for a prospective cancer-control strategy. Cancer Res 46:5276–5281Google Scholar
- 9.Ostertag D, Amundson KK, Espinoza FL, Martin B, Buckley T, da Silva G et al (2012) Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a non lytic retroviral replicating vector. Neuro-oncology 14:145–159PubMedCentralPubMedCrossRefGoogle Scholar
- 10.Aboody KS, Najbauer J, Metz MZ, D’Apuzzo M, Gutova M, Annala AJ, Synold TW, Couture LA, Blanchard S, Moats RA, Garcia E, Aramburo S, Valenzuela VV, Frank RT, Barish ME, Brown CE, Kim SU, Badie B, Portnow J (2013) Neural stem cell-mediated enzyme-prodrug therapy for glioma: preclinical studies. Transl Med Sci. doi: 10.1126/scitranslmed.3005365 Google Scholar
- 12.Paar M, Schwab S, Rosenfellner D, Salmons B, Gunzburg WH, Renner M et al (2007) Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors. J Virol 81:6973–6983PubMedCentralPubMedCrossRefGoogle Scholar
- 19.Ndoye A, Dolivet G, Høgset A, Leroux A, Fifre A, Erbacher P, Berg K, Behr JP, Guillemin F, Merlin JL (2006) Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization. Mol Ther 13:1156–1162PubMedCrossRefGoogle Scholar
- 25.Adachi Y, Tamiya T, Ichikawa T, Terada K, Ono Y, Matsumoto K, Furuta T, Hamada H, Ohmoto T (2000) Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine. Hum Gene Ther 11:77–89PubMedCrossRefGoogle Scholar
- 33.Huber BE, Austin EA, Richards CA, Davis ST, Good SS (1994) Metabolism of 5-fluorocytosine to 5 fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 91:8302–8306PubMedCentralPubMedCrossRefGoogle Scholar
- 34.Williams CW, Buchsbaum DJ, Miller CR (2001) Uracil phosphoribosyltransferase potentiates 5-fluorouracil and cytosine deaminase/5-fluorocytosine cytotoxicity in prostate cancer. Proc Am Assoc Cancer Res 42:455Google Scholar
- 39.Hirschberg H, Zhang MJ, Gach HM, Uzal FA, Chighvinadze D, Sun CH, Peng Q, Madsen SJ (2009) Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol 95:317–329. doi: 10.1007/s11060-009-9930-4 PubMedCentralPubMedCrossRefGoogle Scholar